HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Winston L Hutchinson Selected Research

Serum Amyloid P-Component

10/2012Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.
8/2011Immunoradiometric assay for human serum amyloid P component.
11/2010Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.
3/2010Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.
5/2009Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.
6/2005Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.
6/2004Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination?
1/2002Influenza virus infection is not affected by serum amyloid P component.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Winston L Hutchinson Research Topics

Disease

5Amyloidosis
10/2013 - 03/2010
4Amyloid Plaque
10/2013 - 05/2009
4Inflammation (Inflammations)
10/2013 - 06/2004
2Renal Insufficiency (Renal Failure)
10/2013 - 06/2004
2Acute-Phase Reaction
10/2012 - 06/2005
2Alzheimer Disease (Alzheimer's Disease)
08/2011 - 05/2009
2Proteinuria
03/2010 - 06/2004
2Atherosclerosis
01/2008 - 06/2005
1Pneumococcal Infections
07/2014
1Stroke (Strokes)
11/2010
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
11/2010
1Thrombosis (Thrombus)
01/2008
1Glomerulonephritis
06/2004
1Coronary Disease (Coronary Heart Disease)
08/2003
1Cardiovascular Diseases (Cardiovascular Disease)
08/2003
1Infections
01/2002

Drug/Important Bio-Agent (IBA)

8Serum Amyloid P-ComponentIBA
10/2012 - 01/2002
3C-Reactive ProteinIBA
07/2014 - 08/2003
3Amyloid (Amyloid Fibrils)IBA
10/2013 - 05/2009
3Proline (L-Proline)FDA Link
11/2010 - 05/2009
2AntibodiesIBA
07/2014 - 11/2010
2AA amyloidosisIBA
10/2013 - 06/2004
2Blood Proteins (Serum Proteins)IBA
10/2012 - 05/2009
2Proteins (Proteins, Gene)FDA Link
11/2010 - 08/2003
2pyrrolidineIBA
03/2010 - 05/2009
2Carboxylic AcidsIBA
03/2010 - 05/2009
2Apolipoproteins E (ApoE)IBA
01/2008 - 06/2005
2ApolipoproteinsIBA
01/2008 - 06/2005
1Explosive Agents (Explosives)IBA
10/2013
1Doxycycline (Periostat)FDA LinkGeneric
10/2013
1Complement System Proteins (Complement)IBA
11/2010
1Glycoproteins (Glycoprotein)IBA
11/2010
1Fibrinogen (Factor I)FDA Link
03/2010
1Pharmaceutical PreparationsIBA
03/2010
1CholesterolIBA
01/2008
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2008
1Complement C3 (C3 Complement)IBA
06/2005
1Estrogens (Estrogen)FDA Link
06/2005
1Gonadal Steroid Hormones (Sex Hormones)IBA
06/2005
1amyloid enhancing factorIBA
06/2004
1Antinuclear AntibodiesIBA
06/2004
1Serum Amyloid A Protein (Serum Amyloid A)IBA
06/2004
1Antigen-Antibody Complex (Immune Complex)IBA
06/2004

Therapy/Procedure

2Therapeutics
10/2013 - 11/2010